AK

Abhay Kotwal

Active Director Director DIN 08327970
DIN 08327970 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Abhay Kotwal

Data last updated:

Abhay Kotwal is a Director at Rajesh Pharma Private Limited (since 2019). The company operates in Pharma. Rajesh Pharma Private Limited reported revenue of ₹10.62 Cr (FY 2025).

DIN 08327970
Primary Designation Director
Industry Pharma
First Appointment 11 Jan 2019
Oldest Company Age 28 yrs
Largest company Rajesh Pharma Private Limited · ₹10.62 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rajesh Pharma Private Limited U24232RJ1998PTC015062
Director11 Jan 20191998₹10.62 Cr (FY 2025)Active

Board colleagues of Abhay Kotwal

Directorship timeline

Open interactive timeline →
Rajesh Pharma Private Limited
Premium access

Shareholding and investment profile for Abhay Kotwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhay Kotwal

Abhay Kotwal currently holds 1 directorship: Rajesh Pharma Private Limited (Director, since 11 Jan 2019, revenue ₹10.62 Cr (FY 2025)).

Abhay Kotwal was first appointed on 11 Jan 2019 as Director at Rajesh Pharma Private Limited.

The current boards of Abhay Kotwal's companies include Akshay Kotwal (Rajesh Pharma Private Limited), Babu Lal Gupta (Rajesh Pharma Private Limited), Rajesh Gupta (Rajesh Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available